Job and Career ideas for your kids!


Clinical Research Center News

Unique Research To Study Injuries, Treatment And Outcomes Of Young Athletes

2010-09-09
An estimated 7.2 million secondary school students in the U.S. participate in organized sports that result in approximately 2 million injuries each year, according to the Centers for Disease Control and Prevention. The National Athletic Trainers' Association Education & Research Foundation and Datalys Center for Sports Injury Research and Prevention have teamed up to conduct the first study ...

Stereotaxis highlights clinical outcomes of Niobe Magnetic Navigation System in VT ablation

2010-09-09
Stereotaxis, Inc. highlighted significant new additions to the body of evidence demonstrating exceptional clinical outcomes achieved with its NiobeĀ® Magnetic Navigation System in ventricular tachycardia ablation.

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

2010-09-08
Clinical trials in a variety of areas within interventional cardiovascular medicine that will be presented at TCT 2010 will directly affect the way that people with cardiovascular disease are treated. Breakthroughs in science and medical research, presented exclusively at TCT, will lead to new treatments that are minimally invasive and involve shorter recovery times. Among the topics being ...

Still leery of clinical trials

2010-09-08
The general distrust that African-Americans have of clinical trial research goes back a long way.

Spinal Muscular Atrophy Research Team Receives Pepsi Refresh Funds from Sophia's Cure Foundation

2010-09-08
Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital, along with a team of Spinal Muscular Atrophy (SMA) researchers and clinicians, recently received a $250,000 grant for SMA research and clinic development from Sophia's Cure Foundation via the Pepsi Refresh Project.

ReVision Optics completes enrollment, initial follow up in PresbyLens Phase I clinical trial for presbyopia

2010-09-08
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the ...

NIH Awards $13.23 Million to Children's Hospital Oakland Research Institute Scientist and Team

2010-09-09
The National Institute of Health (NIH) Pharmacogenetics Research Network (PGRN) just awarded $13.23 million to Children's Hospital Oakland Research Institute (CHORI) Senior Scientist Ronald Krauss, MD, for a five-year renewal of his grant, Pharmacogenomics and Risk of Cardiovascular Disease (PARC). Dr. Krauss and the national, interdisciplinary PARC team will use the grant to continue research ...

NewCardio publishes Cardio3KG clinical study for acute cardiac diagnosis

2010-09-09
NewCardio a cardiac diagnostic technology provider, announced today that a clinical study of the Cardio3KG in acute cardiac diagnosis has been published in the August 2010 issue of the peer-reviewed journal, Heart Rhythm, the official journal of the Heart Rhythm Society.

McLean center gives coaching a fresh boost

2010-09-08
In the several decades since professional coaches began hiring themselves out to clients eager to improve some sphere of their existence - work, health, life itself - there has been little research into their fledgling occupation.

Swedish Expands its Scientific Research Program

2010-09-08
- Dr. Mark Reisman named chief scientific officer and head of research SEATTLE, Sept. 8 /PRNewswire-USNewswire/ -- Today, Swedish announced it is expanding its research program to benefit more patients in the Pacific Northwest region. Swedish's goal is to enhance its longstanding research program to provide patients with the latest, most innovative, promising treatments. The program will also ...